Deal Sourcing, Research Collaborations, Search & Evaluation, Spin-offs, start-ups, Communications, Image Building, Investor Relations.
Business Development, Product Licensing, Commercialisation, Distribution, Investor Support, Transactions, M&A, Alliance Management, JVs.
Financing, Investor Pitch Decks, Business Plans, Investor Relations, Sales Forecasts, Market Projections, Due Diligence, Commercial Evaluations, Valuations.
Small private companies may be able to progress the development of their compounds or technologies up to a point, but are normally unable to convert these into commercialised pharmaceutical products, on their own and on a worldwide basis, as they are not capable of setting up the infrastructure for marketing and distribution. The result is that the vast majority of biotech companies will be compelled to enter into corporate deals with pharma companies that have the means to commercialise on a large and global scale.
Our team of executives with years of experience in blue chip multinationals guides companies to success. Integrating our personal experience in senior-level positions in the industry and our network of contacts, Our mission is to empower companies and investors in the life sciences and healthcare industries through comprehensive services spanning financial communications, strategic advisory, financial analysis, and commercialisation. We are dedicated to fostering innovation, growth, and success within the dynamic landscape of healthcare. Our modus operandi is results-focused. We know what has to get done and results have to be delivered. We are here to help: help make a difference.